MRI artifacts in the ferric chloride thrombus animal model: An alternative solution: Preventing MRI artifacts after thrombus induction with a non-ferromagnetic Lewis acid MRI artifacts in the ferric chloride thrombus animal model: An alternative solution : Preventing MRI artifacts after thrombus induction with a non-ferromagnetic Lewis acid

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 9, 2013, Pages 1766-1769

  Wolters, M ^a,b   van Hoof, R H M ^a,c   Wagenaar, A ^b,d   Douma, K ^b,d   van Zandvoort, M A M J ^b,d   Hackeng, T H ^b,d   Post, M J ^b,d   Backes, W H ^a,b   Kooi, M E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CHLORIDE; FIBRIN; HEPARIN; LEWIS ACID;

ARTERY BLOOD FLOW; ARTICLE; ARTIFACT; BLOOD CLOTTING; CAROTID ARTERY; CAROTID ARTERY THROMBOSIS; LASER MICROSCOPY; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; PRIORITY JOURNAL; SIGNAL NOISE RATIO; THROMBUS;

ANIMALS; ARTIFACTS; DISEASE MODELS, ANIMAL; LEWIS ACIDS; MAGNETIC RESONANCE IMAGING; MICE; THROMBOSIS;

EID: 84883819988     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12340     Document Type: Article

References (9)

1. Ciesienski KL, Caravan P. Molecular MRI of Thrombosis. Curr Cardiovasc Imaging Rep 2010; 4: 77-84.
2. Miserus RJ, Herias MV, Prinzen L, Lobbes MB, van Suylen RJ, Dirksen A, Hackeng TM, Heemskerk JW, van Engelshoven JM, Daemen MJ, van Zandvoort MA, Heeneman S, Kooi ME. Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc Imaging 2009; 2: 987-96.
3. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004; 109: 2023-9.
4. Duerschmied D, Meissner M, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von Zur Muhlen C. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis. Invest Radiol 2011; 46: 618-23.
5. von Zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008; 118: 258-67.
6. Ta HT, Prabhu S, Leitner E, Jia F, von Elverfeldt D, Jackson KE, Heidt T, Nair AKN, Pearce H, von Zur Muhlen C, Wang X, Peter K, Hagemeyer CE. Enzymatic Single-Chain Antibody Tagging A Universal Approach to Targeted Molecular Imaging and Cell Homing in Cardiovascular Disease. Circ Res 2011; 109: 365-73.
7. McCarthy JR, Patel P, Botnaru I, Haghayeghi P, Weissleder R, Jaffer FA. Multimodal Nanoagents for the Detection of Intravascular Thrombi. Bioconjug Chem 2009; 20: 1251-5.
8. Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol 2007; 27: 2079-93.
9. Wang X, Xu L. An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 2005; 115: 95-100.